The authors reply
- PMID: 35612460
- DOI: 10.1097/CCM.0000000000005544
The authors reply
Conflict of interest statement
Drs. Reilkoff and Wacker disclosed the off-label product use of vitamin C use in septic shock as an adjuvant therapy. Dr. Proper has disclosed that she does not have any potential conflicts of interest.
Comment on
-
Wacker et al, Who Conclude That Vitamin C Monotherapy Failed to Significantly Reduce Mortality in Septic Shock Patients: Beware of Potential Confounding Factors!Crit Care Med. 2022 Jun 1;50(6):e611-e612. doi: 10.1097/CCM.0000000000005516. Epub 2022 May 19. Crit Care Med. 2022. PMID: 35612459 No abstract available.
References
-
- Honore PM, Redant S, Djimafo P, et al.: Wacker et al, Who Conclude That Vitamin C Monotherapy Failed to Significantly Reduce Mortality in Septic Shock Patients: Beware of Potential Confounding Factors! Crit Care Med 2022; 50:e611–e612
-
- Wacker DA, Burton SL, Berger JP, et al.: Evaluating vitamin C in septic shock: A randomized controlled trial of vitamin C monotherapy. Crit Care Med 2022; 50:e458-e467
-
- Kamel AY, Dave NJ, Zhao VM, et al.: Micronutrient alterations during continuous renal replacement therapy in critically ill adults: A retrospective study. Nutr Clin Pract 2018; 33:439–446
-
- Marik PE, Khangoora V, Rivera R, et al.: Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest 2017; 151:1229–1238
-
- Hwang SY, Ryoo SM, Park JE, et al.; Korean Shock Society (KoSS): Combination therapy of vitamin C and thiamine for septic shock: A multi-centre, double-blinded randomized, controlled study. Intensive Care Med 2020; 46:2015–2025
Publication types
LinkOut - more resources
Full Text Sources
